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ABSTRACT: Combined Plant Mixture (CPM) in ratio of 1:1 (Vitex doniana, Diospyros mesipiliformis, Acacia 
polyacantha, Parinari macrophylla, Ficus sycomorus and Parkia biglobosa) was extracted with methanol and 
screened for antimalarial activity. The CPM Methanol extract residue was suspended in water and fractionated 
with Hexane (HX), Ethylacetate (EA) and n-Butanol (BUT). The Methanolic CPM extract has shows some 
antimalarial activity with Mean Survival Times (MST) of 10.16 to 12.16 days.  All the mice in control group were 
found dead on 14th day of study and one mice was still alive on 14th day in both the groups with 15% and 30% 
parasitaemia against Plasmodium yoelli nigeriensis N67 and Plasmodium berghei K173 respectively.  The EA 
fraction was the most active against P. yoelli nigeriensis N67 having 2 mice surviving up to 14th day with 5.5% 
parasitaemia and MST of 13.4 days. Fractions of water (WT), HX and BUT have 12.5, 25, and 100% (dead) 
parasitaemia with mean survival times of 12.6, 9.33 and 8.5 days against 100% (dead) parasitaemia and 8.20 
days of MST when compared with control. HX fraction was the most active against P. berghei K173 followed by 
BUT fraction with one mice surviving up to 14th day without parasitaemia but with MST of 15.0 and 13.5 days 
respectively.  EA and WT  fractions have 22.66 and 100% (dead) parasitaemia with mean survival times of 11.80 
and 10.80 days respectively. Chromatographic separation of EA fraction of the CPM extract  resulted in the 
isolation of Gallic acid(Figure 2, Fractions 79-83), 3β-OH-α-amyrin(Figure 3, Fractions 45-46), 5,7,3’,4’,5’-
pentahydroxy-3-O-glucophyranoside flavones(Figure 4, Fractions 128-157)-[myricetin 3-O-β-rhamnopyranoside], 
5,7,3’,4’ tetrahydroxy-3-o-glucopyranoside flavones(Figure 5, Fractions 126-141)-[quercetin 3-O-β-
rhamnopyranoside], and  3,5,7,3’,4’-Pentahydroxy flavones (Figure 6, Fractions 87-112)-[quercetine]. The 
compounds were characterized using ESI-MS, IR, 1H C13, HMBC/HSQC and COSY-NMR data. These findings 
suggest that the combined extracts possess antiplasmodial properties.  
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INTRODUCTION 
According to the WHO estimates, there were about 219 
million cases of malaria in 2010 and an estimated 
660,000 deaths. Africa is the most affected continent 
having 90% of malaria deaths (WHO 2012). In Nigeria, 
between 2000 and 2010, around 50% of the population 
had one episode of malaria per year and children below 
5 years had two or four attacks (National Guidelines for 
Diagnosis and Treatment of Malaria, 2011). The 
malaria problem has been exacerbated by chloroquine 
resistant parasite strains which have been reported 
from all parts of Nigeria (Olanrewaju and Johnson, 
2001).  Spread of multidrug-resistant Plasmodium 
falciparum has highlighted the need to develop new 
antimalarial drugs that are affordable for developing 
countries where malaria is prevalent (Vial 1996; 
Wernsdorfer and Trigg 1988). A cornerstone of policies 
to reduce malaria is early diagnosis and prompt 
effective therapy. Recently, combination of plants as 
therapies in Nigeria has emerged as an effective 
alternative to current drugs used in combating malaria 
due to emerging parasite resistance to these agents. 
 
Herbal drugs may provide an option for treatment of 
malaria and may provide alternative to the expensive 
antimalarial drugs. Phytocompounds have been earlier 
used for antiplasmodial activity (Samy et al., 2011). 
Some of the plants used in this study have been 
reported to have pharmacological properties (Atawodi 
2005; Ladeji et al., 2005; Hassan et al., 2007; 
Okpanach, 2010).  
 
Vitex doniana is called Black plum and belongs to the 
family Verbenaceae. It is used locally for the treatment 
of leprosy, genital stimulants and as sedatives. 
Diospyros mesipiliformis, member Ebenaceae, is 
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Jackal berry tree and is traditionally used to stop 
purging, for antimalarial activity and to enhance fertility. 
Acacia polyacantha belongs to the family Fabaceae. It 
is commonly called White-stem thorn and is used 
traditionally to treat snake bites. Parinari macrophylla, 
(Ginger bread plum) belongs to Chrysobalanaceae 
family and is used locally for the treatment of skin 
diseases and malaria. Ficus sycomorus (Bush fig) 
belongs to the family Moraceae and is used for the 
treatment of coughs, dysentery, ringworm and jaundice. 
Parkia biglobosa (African locust bean) belongs to the 
family Fabaceae and is tradomedically used as food 
and medicine (Arnold and Gulumian, 1984, Burkill, 
2000, Mandu and Tengnas, 2005), 
 
The six plants used in the present study are recently 
used in combination for the treatment of malaria in 
Northern Nigeria but their claimed antimalarial 
properties are investigated to obtain potential sources 
of antimalarial agents. To the best of our knowledge 
isolation and characterization of the bioactive principles 
from this combined plant mixture have not been 
reported so far. Therefore, it is worthwhile to present 
report on the activity guided fractionation, isolation and 
characterization of antimalarial agents from these 
plants.        
 
MATERIALS AND METHODS 
Plant Material 
The leaves, roots and stems of the selected plants 
were collected from the adjoining area of Usmanu 
Danfodiyo University (U.D.U.), Sokoto, Nigeria. After 
taxonomic identification at Botany Unit (U.D.U.), the 
plant parts were open air-dried under the shade and 
pulverized into a moderately coarse powder. 
 
Extraction Procedure 
The combined plants parts (leaf, stem bark and root) in 
ratio of 1:1 (Vitex doniana, Diospyros mesipiliformis, 
Acacia polyacantha, Parinari macrophylla, Ficus 
sycomorus and Parkia biglobosa) were extracted with 
methanol three times, concentrated and screened for 
antimicrobial activity. The methanolic residue was 
further suspended in water and extracted with HX, EA 
and BUT as in Figure 1. The procedure was repeated 




Vanillin from BDH, All other chemicals and solvent used 
were of analytical grade. 
 
Animals  
Random breed Swiss mice (20 2g) of either sex were 
procured from the animal facilities of Central Institute of 
Medicinal and Aromatic Plants (CIMAP), Lucknow, 
India. They were maintained on commercial pellet diet 
and water ad libitum under standard housing 
conditions. Ethical guidelines on handling and use of 
experimental animals in accordance with US guidelines 
as contained in National Institute of Health guide for the 
care of laboratory animals (NIH publication no. 18-23)  
and as reported by Zimmerman (1983) were followed. 
 
Malarial parasites  
Rodent malaria parasite Plasmodium yoelii N67 and 
Plasmodium berghei K173 which are chloroquine 
resistant and sensitive respectively were used in this 
study. The parasites were obtained from Central Drug 
Research Institute (CDRI), Lucknow, India. They were 
maintained in normal Swiss mice through sequential 
passages.   
 
Isolation of bioactive compounds from the ethyl 
acetate fraction (EF) of Combined Plant Mixture 
(CPM) 
The ethyl acetate fraction (EF) of Combined Plant 
Mixture (CPM) showed remarkable antimalarial 
activities, hence eight grams (8g) of this fraction were 
subjected to Vacuum Liquid Chromatographic (VLC) 
separation over Silica gel H (average particle size 
approx. 10µm). Stepwise gradient elution of VLC 
column was carried out with hexane, hexane-
chloroform, chloroform, chloroform-methanol and 
methanol. A total of 249 fractions were collected. The 
fractions were pooled on the basis of their TLC profile 
as follows: 
 
Fractions      14-62 (270mg)  
Fractions      63-73 (308mg) 
Fractions      152-184 (325mg) 
Fractions       201-214 (524mg) 
Fractions       215-230 (495mg) 
Fractions       231-246 (1000mg) 
 




Figure 1: General extraction and fractionation procedure. 
 
General experimental procedures 
The 1H and 13C NMR spectra were recorded on a 
Bruker Avance 300 (300MHz). Column chromatography 
was performed with silica gel (60-120 mesh). TLCs 
were run on readymade (Silica gel 60 F254, 0.25mm, 
20x20cm, Merck, Germany) aluminum sheets while 
preparative TLCs were run on (Silica gel 60 F254, 
0.5mm, glass plates 20x20cm) glass plates from Merck, 
Germany. Spots on the TLC plates were visualized by 
spraying with vanillin sulfuric acid and heating the plate 
in oven for 5 minutes at 100 οC. 
 
Antimalarial activity 
Antimalarial potential (blood schizontocidal action) of 
the Combined Plant Mixture (CPM) and its fractions 
(Hexane, Ethylacetate,  Butanol, and water)  were 
evaluated according to the standard protocol (Peters, 
1975) .  Extracts were tested against Plasmodium yoelii 
nigeriensis N67 in Swiss mice at a dose of 1000mg/kg 
body weight with six (6) mice in each group. Six (6) 
doses of extract from day 0 to day 5 were administered 
to each group of mice orally. Artesunate at a dose of 
100 mg/kg was given to one group of mice once a day 
from day 0 to day 4 (5 doses). Mice were infected with 
1×106 parasitized erythrocytes intraperitoneally on day 
0 and the treatment was done after 1 hour. All the five 
extracts were administered once daily by oral route 
starting from the day of infection (day 0) up to 6 days. 
Thin blood smears of individual animals of each group 
of mice were prepared from day 4 and onwards. 
Smears were fixed with methanol and stained with 
Giemsa. These smears were examined for percent 
parasitaemia and their standard derivations were 
calculated. Extracts were also tested against P. berghei 
infected mice at a dose of 1000mg/kg body weight. Six 
(6) mice were used in each group.  Extracts were given 
from day 0 to day 5 (6 doses) to each group of mice 
orally. Chloroquine at the dose of 10 mg/kg was given 
Extracted with n-BuOH (3 x 200 ml) 
Pulverized plant material (50g) 




Extracted with hexane (3 x 200 ml) 
Hexane extract*                                      
Extracted with EtOAc (3 x 200 ml) 
EtOAc extract*                                       Aqueous extract              
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to one group of mice from day 0 day 3 orally. Another 
group of control mice (only infection) received only 
water and food ad libitum. Mice were infected with 1 × 
106 parasitized erythrocytes intraperitoneally on day 0. 
From day 4 and onwards, blood smears were prepared 
from tail vein of the mice and stained with Giemsa stain 
and percentage parasitaemia was recorded by counting 
parasitized erythrocytes. Mortality of the mice was 
recorded daily to obtain the Mean Survival Time (MST). 
 
Mean Survival Time (MST) of infected and extract/drug 
treated batch was obtained by recording the number of 
mice found dead on different days. This number was 
multiplied by the corresponding day when they were 
found dead. The number of mice surviving till the end of 
the experiment (i.e. days 28) was multiplied by 28. 
These days were added and divided by the total 
number of mice.  
 
Statistical Analysis 
Data were subjected to Analysis of Variance (Instat 
software) and a p<0.05 was considered statistically 
significant. 
 
RESULTS AND DISCUSSION 
The methanolic extract showed significant (p<0.05) 
antimalarial activity at 7, 10 and 14 days. The Mean 
Survival Times (MST) of the mice increased by days, 
which were from 8.16±2.40 to 12.16±1.32 as 
compared with control. All the control mice were found 
dead on 14th day, while one mice was still alive on 14th 
day in both groups with 15% and 30% parasitaemia 
(Plasmodium yoelli nigeriensis N67 and Plasmodium 
berghei K173 respectively) (Tables 1 and 2). This 
prompted us to carry out further fractionation of the 
CPM methanolic extract. Hence, the left over 
methanolic extract (40g) was further suspended in 
water and successively fractionated with hexane, 
ethylacetate and n-BuOH (saturated with water).  
 
All the fractions were further screened against P. yoelli 
nigeriensis N67 and P. berghei K173 (Tables 1 and 2). 
From Table 1 it is evident that ethylacetate fraction was 
most active (p<0.05) against P. yoelli nigeriensis N67 
with 2 mice surviving until 14th day having 5.5% 
parasitaemia and MST of 13.4 days when compared 
with control.. The other significantly (p<0.05) active 
fractions were water, hexane and butanol respectively 
with 12.5, 25, and 100% (dead) parasitaemia and mean 
survival times of 12.6, 9.33 and 8.5 days against 100% 
(dead) parasitaemia and 8.20 days MST when 
compared with control. Hence the antimalarial activity 
of the fractions may be represented as: Ethyl acetate 
fraction > hexane fraction > water fraction > BuOH 
fraction 
 
From Table 2, hexane fraction was the most active 
(p<0.05) against P. berghei K173 followed by butanol 
extract with one mice surviving until 14th day having no 
parasitaemia with MST of 15.0 and 13.5 days 
respectively. Other significantly (p<0.05) active 
fractions were ethylacetate and water with 22.66 and 
100% (dead) parasitaemia and mean survival times of 
11.80 and 10.80 respectively when compared with 
control. Thus, antimalarial activity in the fractions may 
be represented as: Hexane fraction > BuOH fraction  > 
ethyl acetate fraction > water fraction 
 
Resistance of Plasmodium falciparum to chemical 
treatment is still important and products isolated from 
medicinal plants that have potent antiplasmodial action 
may represent potential sources of new antimalarial 
drugs (Gasquet et al., 1993).  
 
Results of the antimalarial studies motivated us to carry 
out activity guided separation of ethylacetate fraction of 
the CPM. After a series of chromatographic separation 
as discussed in the experimental section, ethylacetate 
fraction resulted in the isolation and characterization of 
bioactive constituents, Gallic acid (Figure 2,), 3β-OH-α-
amyrin(Figure 3,), 5,7,3’,4’,5’-pentahydroxy-3-O-
glucophyranoside flavones(Figure 4,)-[myricetin 3-O-β-
rhamnopyranoside], 5,7,3’,4’ tetrahydroxy-3-O-
glucopyranoside flavones(Figure 5,)-[quercetin 3-O-β-
rhamnopyranoside] and  3,5,7,3’,4’-Pentahydroxy 
flavones (Figure 6,)-[quercetine]. The compounds were 
characterized using ESI-MS, IR, 1H C13, HMBC/HSQC 
and COSY-NMR data. Phytocompounds are known to 
destroy DNA and inhibit topoisomerase II and are 
involved in elevation of red blood cells oxidation (Etkin, 
1997, Bonjean, 1988). Flavonoids were reported to 
have antiparasitic activities against different strains of 
malaria (Kim et al., 2004, Oliveira et al. 2004, 
Monbrisome et al., 2006). The Flavonoids (Figures 2 to 
6) isolated from the ethyl acetate fraction of CPM may 
be acting in synergy to exert the antimalarial activity 
observed. These compounds were also reported to 
have antioxidant and antibacterial properties (Hassan 
et al., 2013). The results suggest that the combined 
extracts possess antiplasmodial properties. 
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Figure 2: Gallic acid (Fraction 79-83)  
1H NMR (CDCl3, 300 MHz): δ 7.05 (2H, s, H-3 & H-7),  
 
13C NMR (CD3OD, 300 MHz):  170.42 (C-1’), 121.93 (C-1), 
110.30 (CH, C-2), 146.35 (C-3), 139.57 (C-4), 146.35 (C-






Figure 3: 3β-Hydroxy-α-amyrin 
(Fractions 45-46) 
1H NMR (MeOD, 300 MHz):    
 δ 0.77 to 1.14 (24H, 6x ter-Me & 2x sec-Me) 1.3 (1H, 
d, J=6.3Hz, 18α-H), 3.20 (1H, dd, J=5.1, 1.02 3α-H) 
5.20 (1H, t, J=3.0, 12-H) 
 
13C NMR (CDCl3, 300 MHz):  38.76 (CH2, C-1), 27.25 
(CH2, C-2), 78.98 (CH, C-3), 38.76 (C-4), 55.16 (CH, 
C-5), 18.34 (CH2, C-6), 32.91 (CH2, C-7), 39.99 (CH, 
C-8), 47.69 (CH, C-9), 36.88 (C-10), 23.25 (CH2, C-
11), 124.39 (CH, C-12), 139.30 (C-13), 42.03 (C-14), 
28.08 (CH2, C-15), 26.60 (CH2, C-16), 33.73 (C-17), 
59.04 (CH, C-18), 39.59 (CH, C-19), 39.59 (CH, C-
20), 31.23 (CH2, C-21), 41.51 (CH2, C-22), 28.08 
(CH3, C-23), 15.62 (CH3, C-24), 15.62 (CH3, C-25), 
16.84 (CH3, C-26), 23.25 (CH3, C-27), 28.08 (CH3, C-






























Figure 4: (Fraction 128-157) = 5, 7, 3’, 4’, 5’ pentahydroxy-
3-O-glucopyranoside flavones (Myricete 3-O-β-
rhamnopyranoside) 
 
1H NMR (MeOD, 300 MHz): δ 6.13 (1H, d, J = 2.0 Hz, 
H-6), 6.29 (1H, d, J = 2.0 Hz, H-8’), 6.89 (2H, s, H-2’ 
& H-6’), 5.25 (1H, d, J = 1.5 Hz, H-1’’), 3.43 (1H, dd, J 
= 5.7, 9.0 Hz, H-4’’), 3.73 (2H, m, H-2’’& H-3’’), 4.17 
(1H, m, H-5’’), 0.89 (3H, d, J = 6.0 Hz, H-6’’),  
 
13C NMR (MeOD, 300 MHz): δ158.41 (C-2), 136.24 
(C-3), 179.57 (C-4), 163.05 (C-5), 99.81 (C-6), 165.83 
(C-7), 94.72 (C-8), 159.37 (C-9), 105.79 (C-10), 
121.85 (C-1’), 109.59 (C-2’), 146.43 (C-3’), 137.83 (C-
4’), 146.75 (C-5’), 109.59 (C-6’), 103.56(C-2’’), 71.80 
(C-3’’) 73.27 (C-4’’) 79.45 (C-5’’) 72.00 (C-6’’), 17.62 
(C-7’’) 














Figure 5: 5,7,3’,4’-tetrahydroxy-3-O-glucopyranoside 
flavone (Quercetin- 3-O-β-rhamnopyranoside) 
(Fraction 126-141) 
1H NMR (MeOD, 300 MHz):   δ 6.19 (1H, d, J = 2.2 
Hz, H-6), 6.38 (1H, d, J = 2.2 Hz, H-8), 6.88 (1H, d, J 
= 8.4 Hz, H-5’), 7.30 (2H, m, H-2’& H-6’), 5.34 (1H, d, 
J = 1.5 Hz, H-1’’), 3.90 (1H, dd, J = 1.5, 3.3 Hz, H-2’’), 
3.72 (1H, m, H-3’’), 3.45 (1H, m, H-4’’), 4.18 (1H, m, 
H-5’’), 0.93 (3H, d, J = 6.0 Hz, H-6’’) 
 
13C NMR (MeOD, 300 MHz): δ  158.26 (C-2), 132.25 
(C-3), 177.36 (C-4), 162.48 (C-5), 99.29 (C-6), 165.60 
(C-7), 94.36 (C-8), 159.25 (C-9), 103.56 (C-10), 
123.35 (C-1’), 116.72 (C-2’), 147.81 (C-3’), 147.18 (C-
4’), 116.72 (C-5’), 122.93 (C-6’), 103.56(C-2’’), 

























Figure 6: 3,5,7,3’4’-pentahydroxyflavone (Quercetine) 
(Fraction 87-112) 
1H NMR (Py, 300 MHz): δ 6.74 (1H, d, J = 2.2 Hz, H-
6), 6.78 (1H, d, J = 2.2 Hz, H-8), 8.63 (1H, s, H-2’), 
8.10 (1H, d, J = 8.4 Hz, H-6’), 7.40 (1H, d, J = 8.4 Hz, 
H-5’) 
 
13C NMR (Py, 300 MHz): δ  157.26 (C-2), 137.96 (C-
3), 177.36 (C-4), 162.48 (C-5), 99.29 (C-6), 165.60 
(C-7), 94.36 (C-8), 157.50 (C-9), 104.50 (C-10), 
123.35 (C-1’), 116.72 (C-2’), 147.81 (C-3’), 147.18 (C-
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